NCT03800030View on ClinicalTrials.gov

Effect of Cross Frequency tACS on Cognitive Control

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 7, 2018

Primary Completion Date

July 25, 2019

Study Completion Date

July 25, 2019

Conditions
Cognitive ControlExecutive Function
Interventions
DEVICE

Theta-gamma tACS

NeuroConn technologies, direct current-stimulator plus

DEVICE

Delta-beta tACS

NeuroConn technologies, direct current-stimulator plus

DEVICE

Sham tACS

NeuroConn technologies, direct current-stimulator plus

Trial Locations (1)

27599

University of North Carolina, Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT03800030 - Effect of Cross Frequency tACS on Cognitive Control | Biotech Hunter | Biotech Hunter